Juvion

A new approach to neuromuscular health in aging

In production

Status

18.12.2025

Entry date
Problem to solve

A

Proposed solution

A

Request to H4

a

How this project is transforming healthcare: the problem to be solved

• Age-related loss of mobility, which is often underestimated and inadequately addressed
• Deterioration in communication between nerves and muscles as people age
• Increased risk of falls, loss of independence, and high healthcare costs
• Susceptibility to conditions such as sarcopenia and motor neuron disorders
• Current lack of therapies or nutritional solutions that directly target this biological cause

The proposed solution

• Proprietary platform for identifying and validating compounds that support neuromuscular communication
• First product, Juvion 001, a plant-derived compound
• Strong results in animal studies, with up to a 40% reduction in loss of mobility
• Preparing for human validation
• Development of a broader pipeline evaluating safety, neuromuscular health, and mobility, with future potential for memory and sleep

Hands-On support from H4

• Connecting you with key stakeholders to prepare for a pilot human trial
• Assistance in refining the project’s overall strategy
• Access to healthcare professionals
• Connections with potential strategic partners

What impact will this have on the rest of the project?

• Accelerated preparation for the pilot clinical trial
• Strengthened regulatory approach
• Greater integration into the healthcare ecosystem

Summary of privacy policy

This site uses cookies so that we can provide you with the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team understand which areas of the site you find most interesting and useful.

Read more